Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys
Highlights ► An anthrax vaccine was produced by conjugating the capsule to a protein carrier. ► The anthrax capsule conjugate vaccine induced opsono-adherence antibodies. ► The capsule conjugate vaccine protected monkeys against inhalational anthrax. ► The capsule is the first non-toxin antigen show...
Gespeichert in:
Veröffentlicht in: | Vaccine 2012-01, Vol.30 (5), p.846-852 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights ► An anthrax vaccine was produced by conjugating the capsule to a protein carrier. ► The anthrax capsule conjugate vaccine induced opsono-adherence antibodies. ► The capsule conjugate vaccine protected monkeys against inhalational anthrax. ► The capsule is the first non-toxin antigen shown to protect monkeys against anthrax. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2011.12.010 |